This award will fund innovative projects that combine computational and experimental neuroscience approaches to improve understanding of symptoms of anxiety, depression and psychosis.
Projects must address the following research priority:
- A focus on understanding the development, maintenance or resolution of one or more symptoms associated with anxiety, depression and/or psychosis.
Researchers must take a symptom-based approach rather than looking solely at diagnostic categories and are required to provide:
- Evidence that the one or more symptoms chosen are a core feature of anxiety, depression and/or psychosis (broadly defined; the one or more symptoms chosen may be transdiagnostic or specific to one mental health problem).
- A brief explanation of why the one or more symptoms chosen are important for people with lived experience of anxiety, depression and/or psychosis. This could be evidenced through existing qualitative literature and/or focus groups as part of project development.
Eligibility: You can apply to this call if you are a team of researchers:
- from any relevant discipline (Wellcome considers a broad range of disciplines to be relevant to mental health science, including but not limited to those listed in their mental health funding remit)
- from an eligible organisation
- based anywhere in the world (apart from mainland China).
Level of funding: £2-5 million will be provided per project team for a duration of three to five years
Key dates
- 14 May 2024: information webinar
- 09 July 2024: scope check deadline
- 23 July 2024: deadline for applications at 17:00 BST